Lilly now treats computing power as a core part of making medicines—thanks in large part to chief information and digital officer Diogo Rau. Under his leadership, the pharmaceutical giant built LillyPod, an Nvidia-powered supercomputer with more than 1,000 Blackwell GPUs, in just four months. That supercomputer is now modeling biological processes and screening potential molecules before promising candidates enter wet lab experiments.

Rau has also deployed tech in the company’s approach to manufacturing. His team built an AI-assisted digital twin of a bottleneck in Lilly’s production process, testing a slew of temperature and pressure…

Read the full article at TIME.COM